PEJMF (Peijia Medical) ROCE %: -12.53% (As of Dec. 2025)


PEJMF Peijia Medical Ltd PEJMF
76 GF Score
Price $1.39
GF Value $2.75
! 4 Warning Signs
View Full Analysis

What is Peijia Medical ROCE %?

Peijia Medical PEJMF 76 ROCE % is -12.53% as of Dec. 2025. GuruFocus rates PEJMF with a GF Score™ of 76/100 and a GF Value™ of $2.75. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Peijia Medical's annualized ROCE % for the quarter that ended in Dec. 2025 was -12.53%.

Peijia Medical  (OTCPK:PEJMF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Peijia Medical ROCE % Related Terms

Peijia Medical ROCE % Historical Data

* Premium members only.

The historical data trend for Peijia Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peijia Medical ROCE % Chart

Peijia Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -19.77 -13.04 -14.71 -9.01 -9.20

Peijia Medical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.90 -5.47 -12.66 -5.81 -12.53
PEJMF
76GF Score
Peijia Medical Ltd PEJMF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peijia Medical ROCE % Calculation

Peijia Medical's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-27.099/( ( (369.292 - 60.804) + (377.213 - 96.367) )/ 2 )
=-27.099/( (308.488+280.846)/ 2 )
=-27.099/294.667
=-9.20 %

Peijia Medical's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-36.246/( ( (362.222 - 64.511) + (377.213 - 96.367) )/ 2 )
=-36.246/( ( 297.711 + 280.846 )/ 2 )
=-36.246/289.2785
=-12.53 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -12.53% mean?
Peijia Medical (PEJMF) has a ROCE % of -12.53% as of Dec. 2025.
Is Peijia Medical's ROCE % too high?
Peijia Medical's current ROCE % is -12.53%. Overall, Peijia Medical has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Peijia Medical's ROCE % compare to ABT and SYK?
Peijia Medical's ROCE % of -12.53% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peijia Medical's current ROCE % is -12.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peijia Medical stock overvalued right now?
Peijia Medical (PEJMF) has a current ROCE % of -12.53%. The stock's GF Value™ is $2.75, compared to a current price of $1.39 — trading 49.6% below its estimated fair value. The current ROCE % is -12.53%. Peijia Medical's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Peijia Medical (PEJMF), the current ROCE % is -12.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Peijia Medical (PEJMF) Overvalued in 2026?

Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued. The current stock price of $1.39 is trading 49.6% below its estimated GF Value™ of $2.75.

Key valuation signals for PEJMF:

  • ROCE %: -12.53%
  • GF Value™: $2.75 vs. price of $1.39 (49.6% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the PEJMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Peijia Medical Business Description

Other Exchanges 09996:Hong Kong4WO:Germany
Address No.18 Yangjiatian Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
76GF Score

Get the complete analysis for PEJMF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.39
Price
$2.75
GF Value